Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Hybridoma|October 1, 1988
Novel monoclonal antibodies defining epitope of human cytokeratin 18 moleculeL Lauerová, J Kovarik, J Bártek, et al.
Neoplasma|January 1, 1984
Monoclonal antibodies to membrane components of human breast cancer cell line MDA-MB-231. Production and reactivity with various cells in cultureJ Kovarík, J Bártek, L Lauerová, et al.
Neoplasma|January 1, 1980
A prospective study of lymphocyte responses to phytohemagglutinin in melanoma patients. (lack o prognostic value of correlation with minimal tumor burden)J Kovarík, E Ninger, D Zemanová, et al.
Folia Biologica|September 16, 2003
Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patientsV Boudný, I Kocák, L Lauerová, et al.
Folia Biologica|January 1, 1985
Monoclonal antibody to intermediate filaments of cytokeratin type. I. Drug studies and reactivity with cultured cells and tissue sectionsJ Bártek, J Kovarík, L Lauerová, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Monoclonal antibodies against individual cytokeratins in the detection of metastatic spreadJ Kovarík, A Rejthar, L Lauerová, et al.
Neoplasma|January 1, 1985
DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-upM Munzarová, J Kovarík, J Hlávková, et al.
Neoplasma|January 1, 1980
Humoral and cellular immunity in long-term surviving patients with malignant lymphomaP Opat, V Kolár, L Lauerová, et al.
Journal of Biomolecular Structure & Dynamics|September 25, 1999
Monoclonal antibody against DNA adducts with osmium structural probesJ Bůzek, A Kuderová, T Pexa, et al.
Neoplasma|January 1, 1983
Evaluation of the LAI test in patients with benign and malignant breast diseasesJ Kovarík, L Lauerová, E Ninger, et al.
Pageof 3